Type 1 Diabetes – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Type 1 diabetes has traditionally been diagnosed based on clinical catabolic symptoms suggestive of insulin deficiency: polyuria, polydipsia, weight loss, and marked hyperglycemia that is non-responsive to oral agents. It is categorized as an autoimmune disease with progressive b-cell destruction, resulting in a physiological dependence on exogenous insulin. Recent studies have broadened our understanding of the disease but have made diagnosis more complex. Type 1 diabetes care must be an iterative process, adapted as the needs of the individual evolve. In children and adults, clinical assessments for type 1 diabetes should incorporate age-appropriate and complication-focused evaluations based on the possibility that an abnormality will be present. A young adult with common cardiovascular disease (CVD) risk and no complications may need more assessment of lifestyle adjustment than an older adult with a long time of the disease who may need more vascular and neurological issues evaluat